Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Hospitalized COVID-19 Patients with Cardiac Injury
NCT04762771Phase 2Terminated
- Sponsor
- Baptist Health South Florida
- Start
- Dec 2020
- Primary completion
- May 2021
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by Baptist Health South Florida. Started Dec 2020; status: terminated.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04762771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762771.